Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Stuttgart - Delayed Quote EUR

Innovent Biologics, Inc. (6IB.SG)

Compare
4.8400
-0.0600
(-1.22%)
As of 8:09:05 AM GMT+1. Market Open.

Key Executives

Innovent Biologics, Inc.

Description

Corporate Governance

Innovent Biologics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

March 18, 2025 at 10:59 AM UTC - March 24, 2025 at 12:00 PM UTC

Innovent Biologics, Inc. Earnings Date

Recent Events

Related Tickers

196170.KQ ALTEOGEN Inc.
400,000.00
+3.36%
 
MGNX MacroGenics, Inc.
2.2800
-7.32%
 
IPA ImmunoPrecise Antibodies Ltd.
0.3292
-4.08%
 
DNA Ginkgo Bioworks Holdings, Inc.
8.01
-2.79%
 
RXRX Recursion Pharmaceuticals, Inc.
6.59
-12.25%
 
MRNA Moderna, Inc.
30.27
-2.23%